NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-076-2015-2-US-01 METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSES US 62/159,823 Abandoned
NIAAA E-140-2014-0-HK-10 PYRAZOLE DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MEDIATORS HK EP 17105705.6 Issued
NIAAA E-140-2014-0-CA-04 PYRAZOLE DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MEDIATORS CA National Stage 2948349 Issued
NIAAA E-140-2014-0-IE-16 PYRAZOLE DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MEDIATORS IE EP 15728668.3 Issued
NIAAA E-140-2014-0-EP-06 PYRAZOLE DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MEDIATORS EP National Stage 15728668.3 Issued
NIAAA E-140-2014-0-FR-14 PYRAZOLE DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MEDIATORS FR EP 15728668.3 Issued
NIAAA E-140-2014-0-DE-13 PYRAZOLE DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MEDIATORS DE EP 15728668.3 Issued
NIAAA E-140-2014-0-GB-15 PYRAZOLE DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MEDIATORS GB EP 15728668.3 Issued
NIAAA E-140-2014-0-CH-12 PYRAZOLE DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MEDIATORS CH EP 15728668.3 Issued
NIAAA E-140-2014-0-IN-07 PYRAZOLE DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MEDIATORS IN National Stage 201637038171 Issued
NIAAA E-140-2014-0-JP-08 PYRAZOLE DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MEDIATORS JP National Stage 2017-511558 Issued
NIAAA E-140-2014-0-CN-05 PYRAZOLE DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MEDIATORS CN National Stage 201580028788.X Issued
NIAAA E-140-2014-0-US-09 Pyrazole Derivatives And Their Use As Cannabinoid Receptor Mediators US National Stage 15/309,728 10329259 Issued PDF
NIAID E-195-2014-0-PCT-02 Polyvalent Influenza Virus-Like Particles (VLPS) And Use as Vaccines PCT PCT PCT/US2015/029843 Expired
NIAAA E-140-2014-0-PCT-02 Cannabinoid Receptor Mediating Compounds PCT PCT PCT/US2015/029946 Expired
NIAID E-195-2014-0-CN-03 Polyvalent Influenza Virus-Like Particles (VLPS) And Use as Vaccines CN National Stage 201580037799.4 Issued
NIAID E-195-2014-0-EP-04 Polyvalent Influenza Virus-Like Particles (VLPS) And Use as Vaccines EP National Stage 15724151.4 Abandoned
NIAID E-195-2014-0-IN-05 Polyvalent Influenza Virus-Like Particles (VLPS) And Use as Vaccines IN National Stage 201617043281 Abandoned
NCI E-176-2015-0-US-01 COMPOSITIONS AND METHODS FOR THE DETECTION AND TREATMENT OF CERVICAL CANCER AND CERVICAL INTRAEPITHELIAL NEOPLASIA US 62/158,856 Abandoned
NIAAA E-140-2014-0-AU-03 PYRAZOLE DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MEDIATORS AU National Stage 2015255765 Abandoned
CC E-013-2013-0-RU-08 MULTI-FOCI SONICATIONS FOR HYPERTHERMIA TREATMENTS USING MAGNETIC RESONANCE-GUIDED FOCUSSED ULTRASOUND RU National Stage 2015117609 Pending
NCI E-291-2012-0-RU-10 M971 Chimeric Antigen Receptors RU National Stage 2015117237 Issued
NINDS E-122-2014-0-PCT-02 Systems and Methods for a Current Amplifier for Local Coil Pre-Amplification of NMR/MRI Signals PCT PCT PCT/US2015/029674 Expired
NCI E-156-2014-0-PCT-02 Triggering RNA Interference With RNA-DNA And DNA-RNA Nanoparticles PCT PCT PCT/US15/029553 Expired
CC E-091-2014-0-US-01 Electrically Condutive Catheter Inhibiting Bacteria US 62/157,517 Abandoned
NEI E-248-2012-0-US-06 Method of Reducing Adverse Effects in a Cancer Patient Undergoing Treatment with a MEK Inhibitor US National Stage 14/440,218 Abandoned
NIAID E-141-2015-0-US-01 Preventing or Treating Viral Infection by Inhibition of the Histone Methyltransferase EZH1 or EZH2 US 62/155,704 Abandoned
NCI E-149-2015-0-US-01 Methods of Isolating T Cells and T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation From Peripheral Blood US 62/155,830 Abandoned
NIBIB E-135-2015-0-US-01 Trifluoroborate Mimics of Amino Acids and Uses Thereof US 62/155,085 Abandoned
NICHD E-057-2008-0-KR-52 Use Of Ulipristal For Treating Uterine Fibroids KR DIV 10-2015-7011511 Abandoned
NCI E-029-2006-1-US-10 Novel Indenoisoquinoline Derivatives As Anti-proliferative Agents In Cancer Treatment US CON 14/698,335 9399660 Issued PDF
NIAID E-140-2015-0-US-01 Compositions and Methods for Detecting Loa Loa US 62/153,654 Abandoned
NCI E-040-2012-0-HK-10 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen HK National Stage 15104056.6 Pending
NHLBI E-125-2015-0-US-01 METHOD FOR THE SELECTIVE DEPLETION OF ALLOREACTIVE T LYMPHOCYTES FROM DONOR STEM CELL OR LYMPHOCYTE GRAFTS TO PREVENT GRAFT-VERSUS-HOST DISEASE US 62/153,174 Abandoned
CC E-028-2017-0-US-01 DEVICES WITH LOW MELTING POINT ALLOY FOR CONTROL OF DEVICE FLEXIBILITY US 62/153,175 Abandoned
NCI E-054-2013-2-IL-06 IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES IL National Stage 238476 Pending
NHLBI E-186-2014-1-CN-02 SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 CN National Stage 201580033661.7 Issued
NHLBI E-186-2014-1-JP-07 SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 JP National Stage 2017-507931 Issued
NHLBI E-186-2014-1-LI-14 SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 LI EP 15782644.7 Issued
NHLBI E-186-2014-1-EP-06 SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 EP National Stage 15782644.7 Issued
NHLBI E-186-2014-1-GB-13 SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 GB EP 15782644.7 Issued
NHLBI E-186-2014-1-CH-10 SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 CH EP 15782644.7 Issued
NHLBI E-186-2014-1-FR-12 SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 FR EP 15782644.7 Issued
NHLBI E-186-2014-1-DE-11 SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 DE EP 15782644.7 Issued
NHLBI E-186-2014-1-US-05 Superagonists, Partial Agonists and Antagonists of Interleukin-2 US National Stage 15/305,831 1015-08-02 Issued PDF
NCI E-291-2012-0-JP-09 M971 Chimeric Antigen Receptors JP National Stage 2015-539602 Issued
NIDDK E-125-2010-0-US-04 Phantasmidine As A Nicotinic Receptor Agonist With Altered Selectivity Relative To Epibatidine US DIV 14/695,460 9902734 Issued PDF
NHLBI E-186-2014-1-PCT-01 SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 PCT PCT PCT/US2015/027635 Expired
NHLBI E-186-2014-1-IN-03 SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 IN National Stage 201637037839 Pending
NHGRI E-090-2015-0-US-01 Tagged Form Of Mut Enzyme, Genetic Constructs Incorporating It, And Its Use In Gene Therapy US 62/152,520 Abandoned